In conclusion, our results suggest that elevated Δ133p53β occurs on a wild‐type TP53 background and may contribute to multiple tumor‐promoting pathways in glioblastoma by contributing to the immunosuppressive and chemoresistant environment. This evidence concerns the gene TP53 and glioblastoma.